CRGX vs. PRME, RLAY, PROK, MESO, RGNX, HLVX, HUMA, IMTX, KYTX, and CGEM
Should you be buying CARGO Therapeutics stock or one of its competitors? The main competitors of CARGO Therapeutics include Prime Medicine (PRME), Relay Therapeutics (RLAY), ProKidney (PROK), Mesoblast (MESO), REGENXBIO (RGNX), HilleVax (HLVX), Humacyte (HUMA), Immatics (IMTX), Kyverna Therapeutics (KYTX), and Cullinan Oncology (CGEM). These companies are all part of the "biological products, except diagnostic" industry.
CARGO Therapeutics (NASDAQ:CRGX) and Prime Medicine (NYSE:PRME) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, community ranking, media sentiment, risk, analyst recommendations, institutional ownership, profitability, valuation and earnings.
In the previous week, Prime Medicine had 8 more articles in the media than CARGO Therapeutics. MarketBeat recorded 12 mentions for Prime Medicine and 4 mentions for CARGO Therapeutics. CARGO Therapeutics' average media sentiment score of 1.44 beat Prime Medicine's score of 0.61 indicating that CARGO Therapeutics is being referred to more favorably in the media.
93.2% of CARGO Therapeutics shares are owned by institutional investors. Comparatively, 70.4% of Prime Medicine shares are owned by institutional investors. 1.4% of CARGO Therapeutics shares are owned by insiders. Comparatively, 24.3% of Prime Medicine shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
CARGO Therapeutics' return on equity of 0.00% beat Prime Medicine's return on equity.
CARGO Therapeutics currently has a consensus price target of $29.00, suggesting a potential upside of 51.99%. Prime Medicine has a consensus price target of $15.09, suggesting a potential upside of 123.90%. Given Prime Medicine's higher probable upside, analysts clearly believe Prime Medicine is more favorable than CARGO Therapeutics.
Prime Medicine received 7 more outperform votes than CARGO Therapeutics when rated by MarketBeat users. However, 100.00% of users gave CARGO Therapeutics an outperform vote while only 72.22% of users gave Prime Medicine an outperform vote.
Summary
CARGO Therapeutics beats Prime Medicine on 7 of the 12 factors compared between the two stocks.
Get CARGO Therapeutics News Delivered to You Automatically
Sign up to receive the latest news and ratings for CRGX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CRGX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
CARGO Therapeutics Competitors List
Related Companies and Tools
